FOXO3 and cancer: In breast cancer, Wu et al. (60) reported that glucocorticoid receptor (GR)-mediated induction of SGK-1 expression increased cancer cell proliferation by inactivating FOXO3a and that SGK1 activation remarkably decreased the FOXO3a-induced apoptosis in SK-BR-3 breast cancer cells.